151 related articles for article (PubMed ID: 23412358)
1. Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoires.
Morin A; Bardot B; Simeonova I; Lejour V; Bouarich-Bourimi R; Toledo F
Transcription; 2013; 4(2):67-71. PubMed ID: 23412358
[TBL] [Abstract][Full Text] [Related]
2. Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes.
Simeonova I; Lejour V; Bardot B; Bouarich-Bourimi R; Morin A; Fang M; Charbonnier L; Toledo F
PLoS Genet; 2012 Jun; 8(6):e1002731. PubMed ID: 22761580
[TBL] [Abstract][Full Text] [Related]
3. A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs.
Stik G; Laurent S; Coupeau D; Coutaud B; Dambrine G; Rasschaert D; Muylkens B
RNA; 2010 Nov; 16(11):2263-76. PubMed ID: 20881002
[TBL] [Abstract][Full Text] [Related]
4. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins.
Vilas JM; Ferreirós A; Carneiro C; Morey L; Da Silva-Álvarez S; Fernandes T; Abad M; Di Croce L; García-Caballero T; Serrano M; Rivas C; Vidal A; Collado M
Oncotarget; 2015 Feb; 6(5):2992-3002. PubMed ID: 25576924
[TBL] [Abstract][Full Text] [Related]
7. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins.
Böhlig L; Friedrich M; Engeland K
Nucleic Acids Res; 2011 Jan; 39(2):440-53. PubMed ID: 20833636
[TBL] [Abstract][Full Text] [Related]
8. Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.
Su D; Wang X; Campbell MR; Song L; Safi A; Crawford GE; Bell DA
PLoS Genet; 2015 Jan; 11(1):e1004885. PubMed ID: 25569532
[TBL] [Abstract][Full Text] [Related]
9. Identification of p53-target genes in Danio rerio.
Mandriani B; Castellana S; Rinaldi C; Manzoni M; Venuto S; Rodriguez-Aznar E; Galceran J; Nieto MA; Borsani G; Monti E; Mazza T; Merla G; Micale L
Sci Rep; 2016 Sep; 6():32474. PubMed ID: 27581768
[TBL] [Abstract][Full Text] [Related]
10. RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation.
Schade AE; Fischer M; DeCaprio JA
Nucleic Acids Res; 2019 Dec; 47(21):11197-11208. PubMed ID: 31667499
[TBL] [Abstract][Full Text] [Related]
11. Functional evolution of the p53 regulatory network through its target response elements.
Jegga AG; Inga A; Menendez D; Aronow BJ; Resnick MA
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):944-9. PubMed ID: 18187580
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between p53 and p130(Rb2) in induction of cellular senescence.
Kapić A; Helmbold H; Reimer R; Klotzsche O; Deppert W; Bohn W
Cell Death Differ; 2006 Feb; 13(2):324-34. PubMed ID: 16123778
[TBL] [Abstract][Full Text] [Related]
13. The p53 response element and transcriptional repression.
Wang B; Xiao Z; Ko HL; Ren EC
Cell Cycle; 2010 Mar; 9(5):870-9. PubMed ID: 20160511
[TBL] [Abstract][Full Text] [Related]
14. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
Marks J; Saifudeen Z; Dipp S; El-Dahr SS
J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130.
Park AM; Tsunoda I; Yoshie O
J Biol Chem; 2018 Oct; 293(41):15815-15826. PubMed ID: 30166342
[TBL] [Abstract][Full Text] [Related]
16. Preferential binding of p53 tumor suppressor to p21 promoter sites that contain inverted repeats capable of forming cruciform structure.
Coufal J; Jagelská EB; Liao JC; Brázda V
Biochem Biophys Res Commun; 2013 Nov; 441(1):83-8. PubMed ID: 24134839
[TBL] [Abstract][Full Text] [Related]
17. p53 responsive elements in human retrotransposons.
Harris CR; Dewan A; Zupnick A; Normart R; Gabriel A; Prives C; Levine AJ; Hoh J
Oncogene; 2009 Nov; 28(44):3857-65. PubMed ID: 19718052
[TBL] [Abstract][Full Text] [Related]
18. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
Millau JF; Bastien N; Bouchard EF; Drouin R
Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
[TBL] [Abstract][Full Text] [Related]
19. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks.
Menendez D; Shatz M; Azzam K; Garantziotis S; Fessler MB; Resnick MA
PLoS Genet; 2011 Mar; 7(3):e1001360. PubMed ID: 21483755
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
